IDiyas

For the Inventor, By the Inventor

Loerrach, Germany

Hans Allgeier

USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 2.2

ph-index = 6

Forward Citations = 123(Granted Patents)


Location History:

  • Haagen, BD., DE (1976)
  • Haagen, DE (1976 - 1984)
  • Lorrach-Haagen, DE (1979 - 1994)
  • Lorrach, DE (1996 - 2000)
  • Lörrach, DE (2003)
  • Loerrach, DE (2010 - 2013)

Company Filing History:

goldMedal17 out of 6,850 
 
Ciba-geigy Corporation
 patents
silverMedal6 out of 3,923 
 
Novartis Ag
 patents
bronzeMedal1 out of 832,680 
Other
 patents

Years Active: 1976-2013

Loading Chart...
Loading Chart...
24 patents (USPTO):
1. 8513268 - 1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy (2013-08-20),
2. 8299085 - Quinazoline derivatives (2012-10-30),
3. 8012988 - N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihydro-2H-quinazolin-3-yl)methanesulfonamide (2011-09-06),
4. 7655666 - Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands (2010-02-02),
5. 6656957 - Pyridine derivatives (2003-12-02),
6. 6117873 - Substituted aminoalkane phosphonic acids (2000-09-12),
7. 6080743 - 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives (2000-06-27),
8. 5633379 - 3-heteroaliphatyl- and 3-hetero(aryl)aliphatyl-2(1H)-quinolone (1997-05-27),
9. 5488140 - 4-substituted 2-aminoalk-3-enoic (1996-01-30),
10. 5294734 - 4-substituted 2-aminoalk-3-enoic acids (1994-03-15),
11. 5175344 - Unsaturated amino acids (1992-12-29),
12. 5134134 - Unsaturated aminodicarboxylic acid derivatives (1992-07-28),
13. 5110818 - Anticonvulsive substituted-9-benzyl-9H-purines (1992-05-05),
14. 5098922 - Aralkyl-4H-1,2,4-triazole derivatives (1992-03-24),
15. 5051413 - Unsaturated amino acids (1991-09-24),

Title: The Inventive Journey of Hans Allgeier in the Pharmaceutical Industry

Introduction:

Hans Allgeier, a prolific inventor hailing from Loerrach, Germany, has left a lasting impact on the field of pharmaceuticals with his innovative solutions and patented inventions.

Latest Patents:

1. 1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy.

2. Quinazoline derivatives.

Career Highlights:

Having accumulated an impressive total of 24 patents, Hans Allgeier has been at the forefront of pharmaceutical advancements. His patents encompass a wide range of pharmaceutical compositions and treatment methods, showcasing his versatility and deep expertise in the industry.

Collaborations:

During his illustrious career, Hans Allgeier has collaborated with esteemed professionals such as Yves Auberson and Andre Gagneux. His tenure at reputable companies like Ciba-Geigy Corporation and Novartis AG has further strengthened his position as a pioneer in the pharmaceutical sector.

Conclusion:

In conclusion, Hans Allgeier's groundbreaking work in the pharmaceutical field has not only earned him recognition but has also significantly contributed to the advancement of treatment methods and pharmaceutical compositions. His passion for innovation and commitment to excellence continue to inspire generations of inventors in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…